HAHarun Akarsu

Harun Akarsu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Harun Akarsu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Multidimensional Evaluation of Large Language Model Responses to the 2024 ESC Hypertension Guidelines: A Comparative Study

    by Ferit Böyük, Aysun Karahan Gün, İsmail Polat Canbolat, Emre Özmen, Harun Akarsu, Halime Tanrıverdi, Bilal Cuğlan, Kemal Türker Ulutaş

    Large language models (LLMs), including ChatGPT, Gemini, and DeepSeek, are increasingly used in medicine; however, their performance across multiple clinically relevant domains remains incompletely understood. This cross-sectional comparative study evaluated 225 responses generated by three LLMs to 75 clinical questions selected from the 2024 European Society of Cardiology (ESC) Hypertension Guidelines. Responses were independently assessed by two board-certified cardiologists across five predefined domains: accuracy, clinical relevance, completeness, absence of bias and misinformation, and consistency. No statistically significant differences were observed among the three models in accuracy, clinical relevance, completeness, or absence of bias and misinformation (all p > 0.05). A significant difference was identified in response consistency (p = 0.032), with post hoc analysis demonstrating a significant difference between ChatGPT and Gemini. Overall appropriateness scores did not differ significantly among the three LLMs (p = 0.227). These findings suggest that, although overall performance was comparable, response consistency represents an additional dimension that should be considered when evaluating LLMs for guideline-based clinical applications. Future studies incorporating broader clinical scenarios and updated LLM versions are warranted to further define their role in clinical decision support.

  • Differential Biventricular Strain Recovery With Selective Fibrosis Biomarker Regression After Sleeve Gastrectomy: A Prospective CMR Feature-Tracking Study

    by Harun Akarsu, İsmail Doğu Kılıç, Yavuz Dodurga, İpEk Büber, Özge Özden Kayhan, Yiğit Davutoğlu, Serkan Ünlü, Muhammed Raşid Aykota, Furkan Ufuk, Emre Özmen, et al.

    Purpose Obesity injures the heart through hemodynamic, fibrotic, and adipokine pathways, but whether these reverse together or on different timelines after bariatric surgery is unknown. We performed, to our knowledge, the first integrated assessment of biventricular and biatrial cardiovascular magnetic resonance feature-tracking (CMR-FT), fibrosis and adipokine biomarkers, cardiovascular risk, and quality of life after laparoscopic sleeve gastrectomy (LSG), testing whether recovery is uniform or uneven. Materials and Methods In this single-center prospective cohort, 40 patients underwent LSG; 8 were lost to follow-up, leaving 32 (28 with paired CMR; 26 women; aged 36.3 ± 7.6 years; baseline BMI 41.1 ± 4.8 kg/m²) studied before and a median 8.4 months after surgery. Results Left ventricular mass declined from 93.3 to 78.9 g (p < 0.001), alongside improved LVGLS (16.0 to 18.6%, p = 0.003), MAPSE (p = 0.004), and LVEF (p = 0.021). RVEF increased (p = 0.013) without parallel change in RVGLS or TAPSE. Left atrial volume index was unchanged, with only a reservoir-strain trend toward improvement (p = 0.059). Only galectin-3 and endotrophin declined (both p < 0.001); FABP4, apelin, and adiponectin were unchanged. NT-proBNP rose (p < 0.001) despite falling blood pressure and improving strain. Metabolic risk factors improved broadly; Framingham risk and all SF-36 domains improved (p < 0.001). Conclusion Cardiac reverse remodeling after LSG is measurable but uneven within the first year. LV longitudinal mechanics improved alongside mass regression, whereas RVEF rose without parallel longitudinal change, consistent with afterload reduction rather than intrinsic RV recovery. Fibrosis-linked galectin-3 and endotrophin declined while adipokines remained static, indicating distinct fibrotic and adipokine timelines. The components that respond earliest are those that conventional preoperative assessment overlooks. Graphical Abstract

  • Impact of Laparoscopic Sleeve Gastrectomy on Pulmonary Arterial Stiffness and Right Ventricular Function in Obese Patients

    by Ipek Büber, Muhammed Rasid Aykota, Cihan İlYas Sevgican, Derya Kaya, Harun Akarsu, Isık Tekin, Ismail Dogu Kılıc

    Introduction Pulmonary hypertension (PH) is a serious condition associated with high morbidity and mortality, with obesity identified as a significant risk factor. Pulmonary arterial stiffness (PAS) is an early marker of PH, often preceding clinical symptoms. While laparoscopic sleeve gastrectomy (LSG) has been shown to improve various cardiac parameters in obese patients, its impact on PAS and right ventricular (RV) function in the absence of PH remains unclear. This study investigates the effects of LSG on PAS and RV function in obese patients without pre-existing PH. Methods A cohort of 54 patients with obesity who underwent LSG between January and June 2023 at the University hospital was prospectively studied. Patients were evaluated preoperatively and six months postoperatively using comprehensive echocardiographic assessments. Key parameters measured included tricuspid annular systolic velocity (TAS), tricuspid regurgitation velocity (TRV), pulmonary flow acceleration time (PFAT), pulmonary artery velocity, and PAS. Statistical analyses were conducted using paired t-tests and the Wilcoxon signed-rank test. Results Significant improvements were observed in several echocardiographic and hemodynamic parameters post-LSG. PAS showed a notable reduction from 2.44 ± 0.68 preoperatively to 1.74 ± 0.32 postoperatively (p < 0.001). Additionally, significant decreases were observed in TRV (2.00 ± 0.30 m/sec to 1.79 ± 0.40 m/sec, p = 0.025) and systolic pulmonary artery pressure (SPAP) (21.28 ± 4.69 mmHg to 18.36 ± 5.28 mmHg, p = 0.025). Improvements in RV function were indicated by an increase in tricuspid annular plane systolic excursion (TAPSE) from 17.68 ± 4.17 mm preoperatively to 21.18 ± 3.53 mm postoperatively (p < 0.001). Conclusions LSG significantly reduces PAS and improves RV function in obese patients, even in the absence of PH. These findings suggest that LSG may offer protective effects on pulmonary vascular health, highlighting its potential as a therapeutic intervention for reducing PH risk in obese patients. Further research is warranted to explore the long-term cardiovascular benefits of LSG in diverse populations.


  • Open Access

    A FREE FLOATING LEFT ATRIAL BALL THROMBUS TREATMENT WITH ORAL ANTICOAGULATION

    by Harun Akarsu, Asuman Kaftan, Yiğit DAVUTOĞLU, Gürsel Şen

    Transesophageal echocardiography (TEE) revealed a free-floating left atrial ball thrombus in a 56-year-old male patient who was taking warfarin for mechanical prosthetic mitral valve and had recently short-term warfarin interruption for noncardiac surgery and bridging with enoxaparin was admitted to an external center for left abdominal pain and after the detection of spleen and renal infarct, the patient was referred to us for further examination. The patient, who was considered to be at high risk for surgical intervention by the cardiac surgeons, was treated with a warfarin regimen and on the 14th day of the treatment, computed tomography (CT) scan showed that the thrombus disappeared. According to this case report, if patients who have a free-floating left atrial ball thrombus are at high risk for surgical intervention, warfarin therapy can be considered as an alternative to surgery.